SNN – Smith & Nephew plc

Smith & Nephew SNATS, Inc.

SNN

$27.80

Name : Smith & Nephew SNATS, Inc.

Sector : Healthcare

Industry: Medical Devices

Mark. Cap: $11,634,724,864.00

EPSttm : 1.46

Smith & Nephew SNATS, Inc.

$27.80

0.75%

$0.21

SNN — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

1.49

Margin Of Safety %

Put/Call OI Ratio

0.78

EPS Next Q Diff

EPS Last/This Y

0.78

EPS This/Next Y

0.19

Price

Target Price

31.81

Analyst Recom

Performance Q

-8.8

Upside

16.2%

Beta

0.55

Ticker: SNN

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-08-18	SNN	30.17	1.00	999.99	20145
2026-08-19	SNN	29.3	1.00	1.00	20146
2026-08-20	SNN	29.03	1.00	999.99	20149
2026-08-21	SNN	29.27	1.00	999.99	20149
2026-08-24	SNN	29.64	1.00	999.99	20149
2026-08-25	SNN	29.22	1.00	999.99	20149
2026-08-26	SNN	29.31	1.00	999.99	20149
2026-08-27	SNN	29.14	0.65	0.00	132
2026-08-28	SNN	28.99	0.57	0.09	143
2026-08-31	SNN	28.77	0.58	0.00	145
2026-09-02	SNN	28.67	0.63	0.00	137
2026-09-03	SNN	28.68	0.62	0.00	138
2026-09-04	SNN	28.88	0.61	1.00	140
2026-09-08	SNN	27.86	0.61	0.00	142
2026-09-09	SNN	27.8	0.61	0.00	142
2026-09-10	SNN	27.62	0.55	999.99	152
2026-09-11	SNN	27.49	0.81	1.00	177
2026-09-14	SNN	28.42	0.81	0.50	179
2026-09-15	SNN	28	0.80	0.00	185
2026-09-16	SNN	27.82	0.78	999.99	187
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-08-18	SNN	30.17	-	-79.5	2.22
2026-08-19	SNN	29.31	-	-114.4	2.22
2026-08-20	SNN	29.05	-	-92.9	2.22
2026-08-21	SNN	29.28	-	-93.8	2.22
2026-08-24	SNN	29.64	-	-84.9	2.22
2026-08-25	SNN	29.22	-	-104.4	2.22
2026-08-26	SNN	29.30	-	-91.8	2.22
2026-08-27	SNN	29.14	-	-98.2	2.22
2026-08-28	SNN	28.97	-	-100.7	2.22
2026-08-31	SNN	28.77	-	-98.8	2.22
2026-09-01	SNN	28.97	-	-91.1	2.22
2026-09-02	SNN	28.67	-	39.9	2.22
2026-09-03	SNN	28.69	-	48.2	2.22
2026-09-04	SNN	28.88	-	52.6	2.22
2026-09-08	SNN	27.86	-	29.6	2.22
2026-09-09	SNN	27.80	-	56.1	2.22
2026-09-10	SNN	27.62	-	49.8	2.22
2026-09-11	SNN	27.48	-	45.3	2.22
2026-09-14	SNN	28.41	-	94.3	2.22
2026-09-15	SNN	28.00	-	49.0	2.22
2026-09-16	SNN	28.00	-	49.0	2.22
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-08-18	SNN	0.00	-12.72	1.21
2026-08-19	SNN	0.00	-12.72	1.21
2026-08-20	SNN	0.00	-12.72	1.21
2026-08-21	SNN	0.00	-12.72	1.21
2026-08-24	SNN	0.00	-2.50	1.21
2026-08-25	SNN	0.00	-2.50	1.21
2026-08-26	SNN	0.00	-2.50	1.17
2026-08-27	SNN	0.00	-2.50	1.17
2026-08-28	SNN	0.00	-2.50	1.17
2026-08-31	SNN	0.00	-2.52	1.17
2026-09-01	SNN	0.00	-2.52	1.17
2026-09-02	SNN	0.00	-2.52	1.17
2026-09-03	SNN	0.00	-2.52	1.17
2026-09-04	SNN	0.00	-2.52	1.17
2026-09-08	SNN	0.00	-2.65	1.17
2026-09-09	SNN	0.00	-2.65	1.17
2026-09-10	SNN	0.00	-2.65	1.17
2026-09-11	SNN	0.00	-2.65	1.49
2026-09-14	SNN	0.00	-3.30	1.49
2026-09-15	SNN	0.00	-3.30	1.49
2026-09-16	SNN	0.00	-3.30	1.49
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

0.53

Avg. EPS Est. Next Quarter

0.71

Insider Transactions

Institutional Transactions

-3.3

Beta

0.55

Average Sales Estimate Current Quarter

1560

Average Sales Estimate Next Quarter

1816

Fair Value

30.41

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

27.8

Max Drawdown 5-Year %

-40.1

Target Price

31.81

P/E

18.96

Forward P/E

11.63

PEG

1.23

P/S

1.85

P/B

2.27

P/Free Cash Flow

13.71

EPS

1.47

Average EPS Est. Cur. Y

2.22

EPS Next Y. (Est.)

2.41

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

10.08

Relative Volume

0.51

Return on Equity vs Sector %

-13.8

Return on Equity vs Industry %

0.8

EPS 1 7Days Diff

EPS 1 30Days Diff

0.04

EBIT Estimation

◆ SNN Healthcare

$27.82

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

20/20

Pullback

13/25

Volume

11/15

Valuation

16/20

TP/AR

0/10

Options

3/10

RSI

38.3

Range 1M

17.8%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

7/25

Growth

7/30

Estimates

5/20

Inst/Vol

0/15

Options

5/10

EPS Yr

7.6%

EPS NY

52W%

5.4%

💎

Long-Term Value

Quality companies, undervalued

WEAK

🟢 BUY +50.9% upside

Quality

12/30

Valuation

16/30

Growth

6/25

Stability

5/10

LT Trend

4/5

Upside

+50.9%

Quality

MoS

SNN — P/E HistoricalMedical Devices

Smith & Nephew SNATS, Inc.

Sector: Healthcare

Industry: Medical Devices

Employees: 17000

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. The company also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, it provides arthroscopic enabling technologies comprising fluid management equipment for surgical access, cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, the company offers advanced wound care products for the treatment and prevention of acute and chronic wounds, leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.

SNN

Latest News

—

Caricamento notizie per SNN…

stock quote shares SNN – Smith & Nephew plc Stock Price stock today

news today SNN – Smith & Nephew plc stock forecast ,stock prediction 2023 2024 2025

marketwatch SNN – Smith & Nephew plc yahoo finance google finance

stock history SNN – Smith & Nephew plc invest stock market

stock prices SNN premarket after hours

ticker SNN fair value insiders trading

SNN – Smith & Nephew plc

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: SNN

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y